Dieckman Biotechnology is a rapidly expanding high-tech enterprise focused on the research, development, and production of functional small molecular components and peptides. Utilizing modern synthesis, extraction, and enzymatic catalysis technologies, the company offers a wide range of products including cosmetic active ingredients, functional health food dietary products, and flavors and fragrances. Dieckman primarily serves domestic and international clients in the biological, pharmaceutical, tobacco, health care products, and cosmetics sectors. The business model revolves around the sale of these specialized ingredients and the provision of customized raw material solutions and multi-dimensional product application services. Revenue is generated through direct sales and customized service contracts. The company is recognized for its innovation, holding over 40 patents, particularly in the field of ceramides. Dieckman Biotechnology's team comprises professors, PhDs, masters, and experienced professionals, positioning it as a leader in its industry.

Keywords: small molecules, peptides, cosmetics, health foods, fragrances, enzyme catalysis, ceramides, biotechnology, innovation, customization.